Drug Database
CA

carbamazepine (carbamazepine, Elan / Bipotrol / Carbatrol)

✓ Approved

Shire · SCN1A · 小分子

什么是 carbamazepine?

carbamazepine 是一种小分子,由Shire研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名carbamazepine, Elan, Bipotrol, Carbatrol
公司Shire
药物类别小分子
分子靶点SCN1A, SCN2A, SCN3A
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

carbamazepine 作用于 3 个分子靶点:

SCN1Asodium voltage-gated channel alpha subunit 1 (DEE6B, FEB3)
SCN2Asodium voltage-gated channel alpha subunit 2 (Na(v)1.2, BFNIS)
SCN3Asodium voltage-gated channel alpha subunit 3 (Nav1.3, NAC3)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

carbamazepine 针对 3 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersEpilepsy✓ Approved
Nervous system disordersTrigeminal neuralgia✓ Approved
Psychiatric disordersBipolar disorder✓ Approved

相关研究文献

PubMedEnvironmental science & technology2026-11-17

Ammonia Triggers Interfacial Breakpoint Chlorination to Enhance Micropollutant Degradation and Reshapes Chlorinated Byproduct Formation during Electrochlorination.

Hua Zhechao Z, Zhu Jierui J, He Dequan D, Zeng Zhiyuan Z et al.

Electrochlorination is a promising technology for micropollutant degradation in decentralized water treatment. However, ammonia can alter chlorine chemistry. This study investigates the effect of ammonia on micropollutant degradation and chlorinated byproduct formation during electrochlorination using the RuO2/IrO2-Ti anode. Compared to electrochlorination at 10 mM chloride without ammonia, the presence of 1 mM ammonia increased the degradation rate constants of metronidazole and carbamazepine by 2.7- and 4.5-fold, respectively. This enhancement is consistent with interfacial breakpoint chlorination, defined as preferential chlorine-ammonia conversion within an anode-adjacent, chlorine-rich aqueous diffusion layer before complete bulk mixing. During electrochlorination with ammonia, dissolved HO• contributed to micropollutant degradation. Electron paramagnetic resonance provided qualitative evidence of HO• formation, whereas nitrobenzene was used as a probe to quantify its steady-state concentration. The ammonia-induced steady-state HO• concentration reached 2.4 × 10-13 M at 1 mM ammonia, whereas the HO• contribution was negligible without ammonia. Meanwhile, 1-5 mM ammonia reduced the total yields of chlorinated byproducts by only 25-31% during electrochlorination. The limited suppression is consistent with concurrent competition between ammonia and dissolved organic matter for locally generated chlorine within the anode-adjacent region. These findings identify near-anode chlorine-ammonia conversion as a route to reactive-species formation and micropollutant degradation, while showing that chlorinated byproducts remain a concern in ammonia-containing electrochlorination systems.

PMID 43043266
阅读全文 →
PubMedFrontiers in medicine2026-11-17

Vanishing bile duct syndrome reports and recorded fatal outcomes in FAERS: a disproportionality analysis.

Yin Yi Y, Zhang Guiju G

Vanishing bile duct syndrome (VBDS) is a rare but life-threatening condition characterized by progressive destruction of intrahepatic bile ducts, often leading to cirrhosis and death. Large-scale pharmacovigilance studies systematically investigating VBDS reports, particularly those with reported fatal outcomes, remain scarce. We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2004 Q1-2025 Q4). VBDS reports were identified using the MedDRA preferred term "Vanishing bile duct syndrome" (Code 10054753). We applied four algorithms-reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and empirical Bayesian geometric mean (EBGM). A positive signal required meeting criteria for all four methods simultaneously. For drugs meeting signal criteria, we further performed a two-dimensional cross-analysis by intersecting drugs with the highest total report counts and those with the highest death counts, to identify drugs appearing in both top-10 rankings. After deduplication, 19,588,161 unique adverse event reports were available, among which 997 reports coded as VBDS were identified. A death outcome was recorded in 193 reports (19.36%); this proportion reflects FAERS reporting patterns and should not be interpreted as VBDS-attributable mortality or a clinical case-fatality estimate. Disproportionality analysis identified 48 drugs meeting all four signal criteria. Notably, only carbamazepine explicitly mentioned VBDS in its FDA label, and merely 18 of the 48 drugs included the broader term "cholestasis". Through cross-analysis of total report counts and reported death counts, six drugs appeared in both top-10 ranking lists: ibuprofen, ciprofloxacin, azithromycin, sulfamethoxazole-trimethoprim, avacopan, and celecoxib. This large-scale pharmacovigilance analysis of FAERS suggests the mention of VBDS among FDA product labels differs across drugs generating post-marketing safety signals, and that this difference warrants further regulatory and clinical evaluation. Six agents (ibuprofen, ciprofloxacin, azithromycin, sulfamethoxazole-trimethoprim, avacopan, celecoxib) appeared in both top-10 ranking lists for total VBDS reports and reported death counts. Because these rankings are based on descriptive absolute FAERS report counts, these agents warrant further clinical and pharmacovigilance evaluation, particularly in patients with pre-existing risk factors for DILI. These findings may support pharmacovigilance surveillance and hypothesis generation, but should be interpreted as reporting associations rather than the evidence of causality.

PMID 43041357
阅读全文 →
PubMedAnalytical biochemistry2026-11-16

Bimetallic Silver-Gold Nanoparticle-Decorated Nitrogen-doped Graphite Platform for Sensitive Electrochemical Therapeutic Monitoring of an Antiepileptic Drug.

Soliman Shymaa S SS, Mahmoud Amr M AM, Hussein Ola G OG

Carbamazepine is a cornerstone therapy for epilepsy and several neurological disorders; however, its narrow therapeutic range and pronounced pharmacokinetic variability necessitate reliable quantification. Herein, a nanostructured electrochemical sensing platform based on a silver-gold/nitrogen-doped graphite-modified carbon paste electrode (Ag-Au/N-doped graphite/CPE) was developed for sensitive and selective carbamazepine determination. Incorporation of the Ag-Au/N-doped graphite nanocomposite enhanced the voltammetric response compared with the bare carbon paste electrode indicating improved interfacial electrochemical properties and charge-transfer behaviour. Electrode composition, supporting-electrolyte pH, and differential pulse voltammetric parameters were systematically optimized. Complementary cyclic voltammetry and electrochemical impedance spectroscopy confirmed improved interfacial charge-transfer characteristics while scan-rate investigations indicated predominantly diffusion-controlled oxidation. Under optimized conditions, differential pulse voltammetry exhibited a linear response over 1.0-100.0 μM with limits of detection and quantification of 0.31 and 0.95 μM, respectively. The method demonstrated satisfactory precision with repeatability and intermediate precision relative standard deviations of 1.901% and 1.995%, respectively. Selectivity was evaluated using individual pharmaceutical compounds and carbamazepine containing mixtures showing interference values ranging from 0.2% to 9.4% under the investigated conditions. Application to commercial Tegretol® tablets yielded 100.21 ± 1.371% of the labeled content. Importantly, the sensor maintained satisfactory quantitative performance in spiked human plasma over 10.0-900.0 μM achieving a limit of detection of 7.45 μM and recoveries of 96.55-99.58%. These findings highlight the synergistic contribution of bimetallic Ag-Au nanoparticles and nitrogen-doped graphite establishing a simple, sensitive, rapid, reproducible, and cost-effective electrochemical approach for carbamazepine determination in pharmaceutical formulations and complex biological matrices.

PMID 43039165
阅读全文 →
PubMedCureus2026-11-15

Toxic Epidermal Necrolysis After Carbamazepine Use in Trigeminal Neuralgia: A Case Report.

Juda Luiza Horta B LHB, Gnoato Giovani C GC

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, potentially life-threatening mucocutaneous reactions, most commonly associated with medication exposure. Early recognition, immediate discontinuation of the suspected causative drug, and intensive supportive care are essential for clinical management. We report the case of a 55-year-old woman who developed TEN following carbamazepine treatment for trigeminal neuralgia. Approximately 24 days after initiating carbamazepine at 200 mg/day, the patient developed malaise, severe pruritus, and erythematous lesions initially affecting the face and trunk. Over the following days, the lesions progressed rapidly to widespread blistering, erosions, and epidermal detachment, with approximately 55% of the body surface area clinically affected. Oral, ocular, and genital mucosal involvement resulted in severe pain, dysphagia, odynophagia, dysuria, dehydration, and conjunctival complications. Carbamazepine was discontinued, and treatment consisted of intensive supportive care, including intravenous and enteral hydration, opioid analgesia, wound and mucosal care, nutritional support, and multidisciplinary management. A nasoenteric feeding tube and urinary catheter were temporarily required because of severe mucosal involvement. Systemic corticosteroids and other systemic immunomodulatory therapies were not administered. The patient showed progressive clinical improvement, with substantial resolution of cutaneous and mucosal lesions, and was discharged with outpatient follow-up recommendations. This case highlights the importance of recognizing severe cutaneous adverse reactions associated with carbamazepine, particularly during the first weeks of treatment. It also illustrates the role of early drug withdrawal, comprehensive supportive care, adequate pain control, and multidisciplinary management in achieving a favorable clinical outcome, even in patients with extensive epidermal involvement.

PMID 43032722
阅读全文 →
PubMedWater research2026-11-14

Adaptive responses and biotransformation of carbamazepine in microalgal-bacterial granular sludge: Microbial succession, functional genes, and toxicity redistribution.

Xue Yongding Y, Liu Jie J, Li Shengqi S, Ji Bin B

The long-term response and removal mechanisms of microalgal-bacterial granular sludge (MBGS) to persistent pharmaceuticals remain poorly understood. MBGS was exposed to carbamazepine (CBZ) at four concentrations (10 μg L-1, 100 μg L-1, 1 mg L-1, 10 mg L-1) for 35 days. Ammonium and phosphate removal were maintained or enhanced, whereas chemical oxygen demand removal was markedly inhibited at 10 mg L-1. Sludge properties changed non-monotonically without a dose-dependent pattern. CBZ removal was dose-dependent and, in batch tests, adsorption-dominated, with an increasing contribution of biodegradation over time, together with a decrease in the protein fraction and the protein-to-polysaccharide ratio of extracellular polymeric substances. Fifteen transformation products were tentatively identified, formed through epoxidation, hydroxylation, oxidation, ring opening, and rearrangement. Their predicted toxicity was endpoint-dependent, with acridine- and acridone-type products more toxic than CBZ, indicating toxicity redistribution rather than detoxification. The filamentous cyanobacterium Microcoleus increased after operation, particularly at 10 μg L-1, and the heterotrophic genera Sphingomonas, Thauera, and Aquimonas increased in CBZ-exposed reactors, while genes involved in nitrogen metabolism, the tricarboxylic acid cycle, and energy conversion shifted in composition. Antibiotic resistance genes, mobile genetic elements, and virulence factor genes also shifted in composition, without consistent dose-dependent enrichment. Overall, CBZ removal decreased with increasing loading, whereas COD removal was markedly affected only at 10 mg L-1. Transformation did not necessarily reduce toxicity. These findings show that treatment performance and transformation-product toxicity should be assessed together when applying MBGS to pharmaceutical-contaminated wastewater.

PMID 43025071
阅读全文 →
PubMedEnvironmental science & technology2026-11-13

Far-UVC Activation of Performic Acid Enables Concurrent Oxidative and Reductive Micropollutant Abatement.

Wen Hailin H, Lu Senhao S, Shang Chii C, Lin Chuanjing C et al.

Conventional UV-driven advanced oxidation and reduction processes generally emphasize one redox regime and can be inhibited by wastewater constituents. Here, we characterize the photochemistry of performic acid (PFA) under 222 and 254 nm irradiation and evaluate the capacity of PFA solution, prepared from H2O2 and formic acid and thus containing residual H2O2 and formate, to generate concurrent oxidative and reductive pathways. Relative to 254 nm, 222 nm irradiation increased the fluence-normalized photodecay rate constants of neutral PFA (PFA0) and its conjugate base (PFA-) by 1.21- and 3.81-fold, respectively. The increase arose from 16.1- and 10.1-fold larger molar absorption coefficients at 222 nm, despite lower fitted innate quantum yields (0.367 and 0.804 molecule photon-1 at 222 nm versus 0.587 and 0.819 molecule photon-1 at 254 nm). The UV222/PFA solution system generated the reductant •CO2- together with oxidative HO• and oxygen-centered organic radicals. Pathway analysis attributed 34% of carbamazepine removal to •CO2- and 19% of naproxen removal to R-O• at 222 nm. Chloride and bromide enhanced fluence-normalized degradation through reactive-halogen chemistry; the largest increases were observed for carbamazepine (47.5-fold at 254 nm and 21.9-fold at 222 nm). In real municipal wastewater, UV222/PFA solution decreased total organic carbon by 33.5% within 60 min, compared with 21.6% under UV254/PFA solution, at an initial PFA concentration of 80 μM. These results suggest far-UVC activation of PFA solution as a dual-redox treatment platform, with the observed advantages maintained in the tested wastewater effluents.

PMID 43024744
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多carbamazepine